Article

Targeted delivery of flagellin by nebulization offers optimized respiratory immunity and…

medRxiv · 2024 · Baldry, M.; Costa, C.; Zeroual, Y.; Cayet, D.; Pardessus, J.; Soulard, D.; Wallet, F.; Beury, D.; Hot, D.; MacLoughlin, R.; Heuze-Vourc'h, N.; Carnoy, C.; Sirard, J.-C.

Key facts

Title Targeted delivery of flagellin by nebulization offers optimized respiratory immunity and defense against pneumococcal pneumonia
First author Baldry, M.; Costa, C.; Zeroual, Y.; Cayet, D.; Pardessus, J.; Soulard, D.; Wallet, F.; Beury, D.; Hot, D.; MacLoughlin, R.; Heuze-Vourc'h, N.; Carnoy, C.; Sirard, J.-C.
Journal medRxiv
Published Jan 1, 2024
DOI 10.1101/2024.06.17.599391
Devices mentioned K070642, K103635, K232507
Product codes mentioned CAF, PFF, PFT

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature